SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-22-145085
Filing Date
2022-05-09
Accepted
2022-05-09 16:49:52
Documents
1
Effectiveness Date
2022-05-09

Document Format Files

Seq Description Document Type Size
1 POS EX d268123dposex.htm POS EX 31691
  Complete submission text file 0001193125-22-145085.txt   32668
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-260754 | Film No.: 22905837
SIC: 2834 Pharmaceutical Preparations